-+ 0.00%
-+ 0.00%
-+ 0.00%

ADLAI NORTYE ANNOUNCES FIRST PATIENT DOSED IN INTERMITTENT WEEKLY DOSING ARM OF GLOBAL PHASE 1 TRIAL OF PAN-RAS(ON) INHIBITOR AN9025

Reuters·07/16/2026 11:00:00

Please log in to view news